Canary Speech Secures $13 Million

Canary Speech, a voice biomarker health tech company, has secured $13 million in funding to advance its technology for mental and cognitive health screening.

Canary has nine patents protecting the use of vocal biomarkers in healthcare. Canary aims to expand its team to support advancements in artificial intelligence and the healthcare industry's demand for more advanced tools. Its vocal biomarker technology has a wide range of applications within the healthcare industry, including contact centers, ambient clinical listening, remote patient monitoring, and annual wellness checks. Ambient listening tools enable healthcare providers to focus on patient interactions while automatically documenting clinical notes.

"There are technologies that truly disrupt the way healthcare is administered, and Canary is committed to pioneering vocal biomarkers and ambient listening for the betterment of healthcare," said Henry O'Connell, co-founder and CEO of Canary Speech, in a statement.